Will Coronavirus herald a new era in vaccine innovation?

As this novel coronavirus continues to spread, and the number of people infected with COVID-19 keeps rising, the race is on to develop a vaccine. But the time it takes to carry out clinical trials, to ensure that a vaccine is both safe and effective, means this won’t happen overnight.

However, with at least 35 coronavirus vaccines now being developed, even compared to recent pandemics, we have new tools available that could help us reach that goal in record time.

Read more on the Gavi website here.

Leave a Reply

Your email address will not be published.

You May Also Like

Request for Expressions of Interest: Zero-Dose Economics Hub

ThinkWell is currently seeking to select three countries to form a Zero-Dose Economics Hub and welcomes expressions of interest (EOI) from interested research institutes based in low and middle-income countries to participate in the Hub. Hub members will generate critical economic evidence on reaching zero-dose children, and strengthen their capacity to conduct such economic analyses. … Continued

Linked Community News December 2022

This newsletter is available in English, French, Portuguese, Spanish, and Russian. The Linked Immunisation Action Network is invigorated following our workshop in Colombo, Sri Lanka, which brought together stakeholders from Bhutan, India, Indonesia, Pakistan, Philippines, Sri Lanka, and Vietnam to discuss good practices and promising approaches in Clearing Immunisation Backlogs and Building Back Better in … Continued